medvisМедицинская визуализацияMedical Visualization1607-07632408-9516RDS-Media Ltd.10.24835/1607-0763-2020-3-26-36medvis-948Research ArticleCOVID-19COVID-19COVID-19. Поражение печени – особенности визуализации и возможные причиныCOVID-19. Liver damage – visualization features and possible causeshttps://orcid.org/0000-0002-0745-3438ВинокуровА. С.VinokurovA. S.

 Винокуров Антон Сергеевич – старший лаборант кафедры лучевой диагностики и терапии медико-биологического факультета; врач-рентгенолог отделения МРТ и КТ

117997 Москва, ул. Островитянова, д. 1, Российская Федерация;

109263 Москва, ул. Шкулёва, д. 4, Российская Федерация

Anton S. Vinokurov –senior laboratory assistant of radiology department; radiologist of MRI and CT department

Ostrovityanov str., 1, Moscow, 117997, Russian Federation;

Shkuleva str., 4, Moscow, 109263, Russian Federation

antonvin.foto@gmail.comhttps://orcid.org/0000-0001-8933-6544НикифороваМ. В.NikiforovaM. V.

Никифорова Марина Владиславовна – ординатор кафедры лучевой диагностики и терапии медико-биологического факультета

117997 Москва, ул. Островитянова, д. 1, Российская Федерация

Marina V. Nikiforova – resident of radiology department

Ostrovityanov str., 1, Moscow, 117997, Russian Federation

marina.nikif.802@mail.ruhttps://orcid.org/0000-0002-6870-7286ОганесянА. А.OganesyanA. A.

Оганесян Анна Артуровна – ординатор кафедры лучевой диагностики и терапии медико-биологического факультета

117997 Москва, ул. Островитянова, д. 1, Российская Федерация

Anna A. Oganesyan – resident of radiology department

Ostrovityanov str., 1, Moscow, 117997, Russian Federation

anna4991@mail.ruhttps://orcid.org/0000-0001-5689-7628ВинокуроваО. О.VinokurovaO. O.

Винокурова Ольга Олеговна – канд. мед. наук, ассистент кафедры инфекционных болезней с курсами эпидемиологии и фтизиатрии

117198 ул. Миклухо-Маклая, 6, Москва, Российская Федерация

Olga O. Vinokurova – Cand. of Sсi. (Med.), Assistant Professor of Infectious Diseases Department with Training Courses in Epidemiology and Phthisiology

Miklukho-Maklaya str., 6, Moscow, 117198, Russian Federation

olga.berejnaya12@gmail.comhttps://orcid.org/0000-0002-0310-0889ЮдинА. Л.YudinA. L.

Юдин Андрей Леонидович – доктор мед. наук, профессор, заведующий кафедрой лучевой диагностики и терапии медико-биологического факультета

117997 Москва, ул. Островитянова, д. 1, Российская Федерация

Andrey L. Yudin – Doсt. of Sсi. (Med.), Professor, Professor, Head of Radiology Department

Ostrovityanov str., 1, Moscow, 117997, Russian Federation

https://orcid.org/0000-0002-6020-9434ЮматоваЕ. А.YumatovaE. A.

Юматова Елена Анатольевна – канд. мед. наук, доцент кафедры лучевой диагностики и терапии медико-биологического факультета

117997 Москва, ул. Островитянова, д. 1, Российская Федерация

Elena A. Yumatova – Cand. of Sci. (Med.), associate professor, Radiology Department

Ostrovityanov str., 1, Moscow, 117997, Russian Federation

ФГАОУ ВО “Российский национальный исследовательский медицинский университет имени Н.И. Пирогова” Минздрава России; ГБУЗ “ГКБ имени В.П. Демихова ДЗ города Москвы”РоссияPirogov Russian National Research Medical University of the Ministry of Health of Russia; Demikhov City Hospital of Moscow City Health DepartmentRussian FederationФГАОУ ВО “Российский национальный исследовательский медицинский университет имени Н.И. Пирогова” Минздрава РоссииРоссияPirogov Russian National Research Medical University of the Ministry of Health of RussiaRussian FederationФГАОУ ВО “Российский университет дружбы народов”РоссияPeople’s Friendship University of RussiaRussian Federation2020081020202432636Copyright © Винокуров А.С., Никифорова М.В., Оганесян А.А., Винокурова О.О., Юдин А.Л., Юматова Е.А., 20202020Винокуров А.С., Никифорова М.В., Оганесян А.А., Винокурова О.О., Юдин А.Л., Юматова Е.А.Vinokurov A.S., Nikiforova M.V., Oganesyan A.A., Vinokurova O.O., Yudin A.L., Yumatova E.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://medvis.rdsmedia.ru/jour/article/view/948Цель исследования

Цель исследования: оценить особенности КТ-визуализации печени и возможные причины патологических изменений при COVID-19.

Материал и методы

Материал и методы. Проведен анализ литературы и собственных данных по особенностям КТ-визуализации печени в сочетании с биохимическими анализами у пациентов с COVID-19. Рассмотрены основные возможные причины изменений в печени, а также симптомы при КТ.

Результаты

Результаты. Основной мишенью нового коронавируса SARS-CoV-2 является дыхательная система. Но среди пациентов с COVID-19 наряду с поражением ЦНС, миокарда и кишечника были зарегистрированы случаи повреждения или дисфункции печени. Это выражается в повышении биохимических маркеров повреждения печени, а также в диффузном снижении ее плотности при КТ, которое обычно наблюдают в острой стадии заболевания.

Item

Item. To evaluate the features of CT imaging of the liver and the possible causes of pathological changes in COVID-19.

Materials and methods

Materials and methods. An analysis of the literature and our own data on the features of CT imaging of the liver in combination with biochemical analyzes in patients with COVID-19 was performed. The main possible causes of changes in the liver, as well as symptoms with CT, are examined.

Results

Results. The main target of the new SARS-CoV-2 coronavirus is the respiratory system. But among patients with COVID-19, along with damage to the central nervous system, myocardium, and intestines, cases of liver damage or dysfunction have been reported. This is expressed in an increase in biochemical markers of liver damage, as well as in a diffuse decrease in its density during CT, which is usually observed in the acute stage of the disease.

печеньCOVID-19SARS-CoV-2дистрофиягепатозтрансаминазыКТliverCOVID-19SARS-CoV-2dystrophyhepatosistransaminasesCTReferencesLee I.C., Huo T.I., Huang Y.H. Gastrointestinal and Liver Manifestations in Patients with COVID-19. J. Chin. Med. Assoc. 2020; 10.1097/JCMA.0000000000000319. https://doi.org/10.1097/JCMA.0000000000000319Lee I.C., Huo T.I., Huang Y.H. Gastrointestinal and Liver Manifestations in Patients with COVID-19. J. Chin. Med. Assoc. 2020; 10.1097/JCMA.0000000000000319. https://doi.org/10.1097/JCMA.0000000000000319Патологическая анатомия COVID-19. Атлас / Под об- щей ред. Зайратьянца О.В. М.: ДЗМ, 2020. 116 c.Pathological anatomy of COVID-19. Atlas / Under the general ed. Zairatyantsa O.V. M.: Moscow Department of Health, 2020. 116 p. (In Russian)Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., Müller M.A., Drosten C., Pöhlmann S. SARSCoV- 2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181 (2): 271–280.e8. https://doi.org/10.1016/j.cell.2020.02.052Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., Müller M.A., Drosten C., Pöhlmann S. SARSCoV- 2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181 (2): 271–280.e8. https://doi.org/10.1016/j.cell.2020.02.052Zhang C., Shi L., Wang F.S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol. Hepatol. 2020; 5 (5): 428–430. https://doi.org/10.1016/S2468-1253(20)30057-1Zhang C., Shi L., Wang F.S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol. Hepatol. 2020; 5 (5): 428–430. https://doi.org/10.1016/S2468-1253(20)30057-1Cai Q., Huang D., Yu H., Zhu Z., Xia Z., Su Y., Li Z., Zhou G., Gou J., Qu J., Sun Y., Liu Y., He Q., Chen J., Liu L., Xu L. COVID-19: Abnormal liver function tests. J. Hepatol. 2020; S0168-8278(20)30218-X. https://doi.org/10.1016/j.jhep.2020.04.006Cai Q., Huang D., Yu H., Zhu Z., Xia Z., Su Y., Li Z., Zhou G., Gou J., Qu J., Sun Y., Liu Y., He Q., Chen J., Liu L., Xu L. COVID-19: Abnormal liver function tests. J. Hepatol. 2020; S0168-8278(20)30218-X. https://doi.org/10.1016/j.jhep.2020.04.006Bhayana R., Som A., Li M.D., Carey D.E., Anderson M.A., Blake M.A., Catalano O., Gee M.S., Hahn P.F., Harisinghani M., Kilcoyne A., Lee S.I., Mojtahed A., Pandharipande P.V., Pierce T.T., Rosman D.A., Saini S., Samir A.E., Simeone J.F., Gervais D.A., Velmahos G., Misdraji J., Kambadakone A. Abdominal Imaging Findings in COVID-19: Preliminary Observations. Radiology. 2020; 201908. https://doi.org/10.1148/radiol.2020201908Bhayana R., Som A., Li M.D., Carey D.E., Anderson M.A., Blake M.A., Catalano O., Gee M.S., Hahn P.F., Harisinghani M., Kilcoyne A., Lee S.I., Mojtahed A., Pandharipande P.V., Pierce T.T., Rosman D.A., Saini S., Samir A.E., Simeone J.F., Gervais D.A., Velmahos G., Misdraji J., Kambadakone A. Abdominal Imaging Findings in COVID-19: Preliminary Observations. Radiology. 2020; 201908. https://doi.org/10.1148/radiol.2020201908Chai X., Hu L., Zhang Y., Han W., Lu Z., Ke A. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv 2020.02.03.931766. https://doi.org/10.1101/2020.02.03.931766Chai X., Hu L., Zhang Y., Han W., Lu Z., Ke A. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv 2020.02.03.931766. https://doi.org/10.1101/2020.02.03.931766Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., Tai Y., Bai C., Gao T., Song J., Xia P., Dong J., Zhao J., Wang F.S. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 2020; 8 (4): 420–422. https://doi.org/10.1016/S2213-2600(20)30076-XXu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., Tai Y., Bai C., Gao T., Song J., Xia P., Dong J., Zhao J., Wang F.S. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 2020; 8 (4): 420–422. https://doi.org/10.1016/S2213-2600(20)30076-XZhang Y., Zheng L., Liu L., Zhao M., Xiao J., Zhao Q. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city. Liver Int. 2020; 10.1111/liv.14455. https://doi.org/10.1111/liv.14455Zhang Y., Zheng L., Liu L., Zhao M., Xiao J., Zhao Q. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city. Liver Int. 2020; 10.1111/liv.14455. https://doi.org/10.1111/liv.14455Garrido I., Liberal R., Macedo G. Review article: COVID-19 and liver disease - what we know on 1st May 2020. Aliment Pharmacol. Ther. 2020; 10.1111/apt.15813. https://doi.org/10.1111/apt.15813Garrido I., Liberal R., Macedo G. Review article: COVID-19 and liver disease - what we know on 1st May 2020. Aliment Pharmacol. Ther. 2020; 10.1111/apt.15813. https://doi.org/10.1111/apt.15813Li Q., Zhang J., Ling Y., Li W., Zhang X., Lu H., Chen L. A simple algorithm helps early identification of SARS-CoV-2 infection patients with severe progression tendency. Infection. 2020; 1–8. https://doi.org/10.1007/s15010-020-01446-zLi Q., Zhang J., Ling Y., Li W., Zhang X., Lu H., Chen L. A simple algorithm helps early identification of SARS-CoV-2 infection patients with severe progression tendency. Infection. 2020; 1–8. https://doi.org/10.1007/s15010-020-01446-zLai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int. J. Antimicrob. Agents. 2020; 55 (3): 105924. https://doi.org/10.1016/j.ijantimicag.2020.105924Lai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int. J. Antimicrob. Agents. 2020; 55 (3): 105924. https://doi.org/10.1016/j.ijantimicag.2020.105924Shi J., Li Y., Zhou X., Zhang Q., Ye X., Wu Z., Jiang X., Yu H., Shao L., Ai J.-W., Zhang H., Xu B., Sun F., Zhang W. Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested casecontrol study. BMC Med. 2020; 18 (1): 168. https://doi.org/10.1186/s12916-020-01633-7Shi J., Li Y., Zhou X., Zhang Q., Ye X., Wu Z., Jiang X., Yu H., Shao L., Ai J.-W., Zhang H., Xu B., Sun F., Zhang W. Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested casecontrol study. BMC Med. 2020; 18 (1): 168. https://doi.org/10.1186/s12916-020-01633-7Liu X., Shi S., Xiao J. et al. Prediction of the severity of Corona Virus Disease 2019 and its adverse clinical outcomes. Jpn. J. Infect. Dis. 2020;10.7883/yoken.JJID.2020.194. https://doi.org/10.7883/yoken.JJID.2020.194Liu X., Shi S., Xiao J. et al. Prediction of the severity of Corona Virus Disease 2019 and its adverse clinical outcomes. Jpn. J. Infect. Dis. 2020;10.7883/yoken.JJID.2020.194. https://doi.org/10.7883/yoken.JJID.2020.194Давыдова А.В. Биохимический анализ крови в дифференциальной диагностике заболеваний печени: Учебное пособие для врачей. ГБОУ ВПО ИГМУ Минздрава России. Иркутск: ИГМУ, 2013. 64 с.Davydova A.V. Biochemical analysis of blood in the differential diagnosis of liver diseases: a training manual for doctors; GBOU VPO IGMU of the Ministry of Health of Russia. Irkutsk: IGMU, 2013. 64 p. (In Russian)Корячкин В.А., Эмануэль В.Л., Страшнов В.И. Диагностическая деятельность: учебник для СПО. 2-е изд., испр. и доп. М.: Изд-во Юрайт, 2019. 462 с.Koryachkin V.A., Emanuel V.L., Strashnov V.I. Diagnostic activity: textbook for open source software. 2nd ed. M.: Yurayt Publishing House, 2019. 462 p. (In Russian)Араблинский А.В., Чеченов М.Х. Возможности методов компьютерной томографии и компьютерно-томографической ангиографии в диагностике различной выраженности жировой инфильтрации печени. Диагностическая и интервенционная радиология. 2009; 3 (3): 9–19.Arablinsky A.V., Chechenov M.Kh. The possibilities of computed tomography and computed tomography angiography methods in the diagnosis of various severity of fatty liver. Diagnostic and interventional radiology. 2009; 3 (3): 9–19. (In Russian)Мехтиев С.Н., Гриневич В.Б., Кравчук Ю.А., Бра щенкова А.В. Неалкогольная жировая болезнь печени: клиника, диагностика и лечение. Лечащий врач. 2008; 2: 29–37.Mehdiyev S.N., Grinevich V.B., Kravchuk Yu.A., Brashenkova A.V. Non-alcoholic fatty liver disease: clinic, diagnosis and treatment. Attending doctor. 2008; 2: 29–37. (In Russian)Prompetchara E., Ketloy C., Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac. J. Allergy Immunol. 2020; 38 (1): 1–9. https://doi.org/10.12932/AP-200220-0772Prompetchara E., Ketloy C., Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac. J. Allergy Immunol. 2020; 38 (1): 1–9. https://doi.org/10.12932/AP-200220-0772Feng G., Zheng K.I., Yan Q.Q., Rios R.S., Targher G., Byrne C.D., Poucke S.V., Liu W.Y., Zheng M.H. COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. J. Clin. Transl. Hepatol. 2020; 8 (1): 18–24. https://doi.org/10.14218/JCTH.2020.00018Feng G., Zheng K.I., Yan Q.Q., Rios R.S., Targher G., Byrne C.D., Poucke S.V., Liu W.Y., Zheng M.H. COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies. J. Clin. Transl. Hepatol. 2020; 8 (1): 18–24. https://doi.org/10.14218/JCTH.2020.00018Prompetchara E., Ketloy C., Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac. J. Allergy. Immunol. 2020; 38 (1): 1–9. https://doi.org/10.12932/AP-200220-0772Prompetchara E., Ketloy C., Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac. J. Allergy. Immunol. 2020; 38 (1): 1–9. https://doi.org/10.12932/AP-200220-0772Zhang X.J., Cheng X., Yan Z.Z. et al. An ALOX12-12- HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury. Nat. Med. 2018; 24 (1): 73–83. https://doi.org/10.1038/nm.4451Zhang X.J., Cheng X., Yan Z.Z. et al. An ALOX12-12- HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury. Nat. Med. 2018; 24 (1): 73–83. https://doi.org/10.1038/nm.4451Li H., Xiang X., Ren H., Xu L., Zhao L., Chen X., Long H., Wang Q., Wu Q. Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis. J. Infect. 2020; 80 (6): 646–655. https://doi.org/10.1016/j.jinf.2020.03.035Li H., Xiang X., Ren H., Xu L., Zhao L., Chen X., Long H., Wang Q., Wu Q. Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis. J. Infect. 2020; 80 (6): 646–655.Bangash M.N., Patel J., Parekh D. COVID-19 and the liver: little cause for concern. Lancet Gastroenterol. Hepatol. 2020; S2468-1253(20)30084-4. https://doi.org/10.1016/S2468-1253(20)30084-4https://doi.org/10.1016/j.jinf.2020.03.035Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 5 (08.04.2020).Bangash M.N., Patel J., Parekh D. COVID-19 and the liver: little cause for concern. Lancet Gastroenterol. Hepatol. 2020; S2468-1253(20)30084-4. https://doi.org/10.1016/S2468-1253(20)30084-4Ивашкин В.Т. (ред.). Болезни печени и желчевыводя- щих путей. М.: Издательский дом “М-Вести”, 2002. 416 c.Temporary guidelines. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 5 (04/08/2020). (In Russian)Ивашкин В.Т. Болезни печени и желчевыводящих путей: Руководство для врачей. М.: Издательский дом “М-Вести”, 2005. 536 с.Ivashkin V.T. (ed.). Diseases of the liver and biliary tract. M : Publishing house “M-Vesti”, 2002. 416 p. (In Russian)O’Grady J.G., Alexander G.J., Hayllar K.M., Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989; 97: 439–445.Ivashkin V.T. Diseases of the liver and biliary tract: A Guide for Doctors. M.: Publishing House, 2005. 536 p. (In Russian)Маркова И.В., Афанасьев В.В., Цыбулькин Э.К., Неженцев М.В. Клиническая токсикология детей и подростков. В 2-х томах. Т. 1. СПб.: Интермедика, 1998. 302 с.O’Grady J.G., Alexander G.J., Hayllar K.M., Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989; 97: 439–445.Bessems J.G., Vermeulen N.P. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit. Rev. Toxicol. 2001; 31: 55–138.Markova I.V., Afanasyev V.V., Tsybulkin E.K., Nezhentsev M.V. Clinical toxicology of children and adolescents: in 2 volumes. T. 1. SPb .Intermedika, 1998. 302 p. (In Russian)LiverTox: Clinical and Research Information on Drug- Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012. Chloroquine. [Updated 2017 Feb 2]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK548224/Bessems J.G., Vermeulen N.P. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit. Rev. Toxicol. 2001; 31: 55–138.Mehra M.R., Desai S.S., Ruschitzka F., Patel A.N. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)31180-6LiverTox: Clinical and Research Information on Drug- Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012. Chloroquine. [Updated 2017 Feb 2]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK548224/Ивашкин В.Т., Барановский А.Ю., Райхельсон К.Л., Пальгова Л.К., Маевская М.В., Кондрашина Э.А., Марченко Н.В., Некрасова Т.П., Никитин И.Г. Лекарственные поражения печени (клинические рекомендации для врачей). Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2019; 29 (1): 101–131. https://doi.org/10.22416/1382-4376-2019-29-1-101-131Mehra M.R., Desai S.S., Ruschitzka F., Patel A.N. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)31180-6Белоусов Ю.Б. Лекарственные повреждения печени, ассоциируемые с макролидами. Очевидна ли связь? РМЖ. 2011; 19 (18): 1118.Ivashkin V.T., Baranovsky A.Yu., Raikhelson K.L., Palgova L.K., Maevskaya M.V., Kondrashina E.A., Marchenko N.V., Nekrasova T.P., Nikitin I.G. Medicinal lesions of the liver (clinical recommendations for doctors). Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2019 29 (1): 101–131. https://doi.org/10.22416/1382-4376-2019-29-1-101-131 (In Russian)Andrade R.J., Tulkens P.M. Hepatic safety of antibiotics used in primary care. J. Antimicrob. Chemother. 2011; 66 (7): 1431–1446.Belousov Yu.B. Medicinal liver damage associated with macrolides. Is the connection obvious? Russian Medical Journal. 2011; 19 (18): 1118. (In Russian)Drug Safety Update volume 12, issue 12: July 2019: 2.Andrade R.J., Tulkens P.M. Hepatic safety of antibiotics used in primary care. J. Antimicrob. Chemother. 2011; 66 (7): 1431–1446.Левитова Д.Г., Грачева С.А., Самойлов А.С., Удалов Ю.Д., Праскурничий Е.А., Паринов О.В. Вопросы безопасности лекарственной терапии COVID-19. Архивъ внутренней медицины. 2020; 10 (3): 165–187. https://doi.org/10.20514/2226-6704-2020-10-3-165-187Drug Safety Update volume 12, issue 12: July 2019: 2.Xie H., Zhao J., Lian N., Lin S., Xie Q., Zhuo H. Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study. Liver Int. 2020; 10.1111/liv.14449. https://doi.org/10.1111/liv.14449Levitova D.G., Gracheva S.A., Samoylov A.S., Udalov U.D., Praskurnichiy E.A., Parinov O.V. Safety Considerations for Drug Therapy COVID-19. Archive of Internal Medicine. 2020; 10 (3): 165–187. https://doi.org/10.20514/2226-6704-2020-10-3-165-187 (In Russian)Xie H., Zhao J., Lian N., Lin S., Xie Q., Zhuo H. Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study. Liver Int. 2020; 10.1111/liv.14449. https://doi.org/10.1111/liv.14449Xie H., Zhao J., Lian N., Lin S., Xie Q., Zhuo H. Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study. Liver Int. 2020; 10.1111/liv.14449. https://doi.org/10.1111/liv.14449

The authors declare that there are no conflicts of interest present.